Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
ACC 23: The Evolut Low Risk Trial
Author(s): John Forrest Added: 1 year ago
ACC.23/WCC - We are joined onsite by Dr John Forrest (Yale Valve Clinic, US) in this short video, who outlines the three-year outcomes of the Evolut Low-Risk Trial(Medtronic Cardiovascular) (NCT02701283). This study aimed to compare transcatheter aortic valve replacement (TAVR) using Medtronic's TAVR valve with surgical aortic valve replacement (SAVR) in over 2000 patients with aortic stenosis… View more

Intervention
TCT 22: RADIANCE II: Paradise Renal Denervation in Pts With Hypertension
Author(s): Ajay J Kirtane Added: 1 year ago
TCT 22 - In this short video from TCT 2022, Dr Ajay Kirtane (Columbia University Medical Center and New York-Presbyterian Hospital, NY, US) joins us to discuss the findings of ReCor's RADIANCE II Pivotal trial, which aimed to evaluate the safety and effectiveness of the Paradise renal Denervation System in patients with stage 2 hypertension. 225 patients were randomized to receive either a renal… View more

Prevention & Chronic Conditions

Intervention
Author(s): Roland Klingenberg , Christian M Matter , Danielle Hof , et al Added: 3 years ago
Abstract The introduction of novel high-sensitivity cardiac troponin (hs-cTn) assays has made it possible to measure cardiac troponin levels that are up to 10-fold lower than those detectable by conventional cardiac troponin (cTn) assays. With such novel assays, an elevated risk of major adverse cardiovascular events was noted across the continuum of cTn levels, with an incremental risk of… View more

Anticoagulation
Author(s): Sandeep Nathan , Rajiv Swamy Added: 3 years ago
The spectrum of acute coronary syndromes (ACS) encompasses a broad array of clinical characteristics and risk strata, ranging from unstable angina (UA) and non-ST-segment elevation myocardial infarction (NSTEMI) to ST-segment elevation myocardial infarction (STEMI) and sudden cardiac death (SCD). In this article, UA and NSTEMI will be considered together as non-ST-segment elevation acute coronary… View more

Anticoagulation
Author(s): Judd E Hollander Added: 3 years ago
Ischemic heart disease is the leading cause of death among adults and one of the most common reasons for emergency department (ED) visits across the US. There are approximately five to seven million ED visits for acute chest pain syndromes annually; however, only 5% of these patients are ultimately diagnosed with acute myocardial infarction (AMI) and an additional 10% have non-AMI acute coronary… View more

MI/ACS
Baroreflex Activation Therapy for Resistant Hypertension and Heart Failure
Author(s): Deepak L Bhatt , Anna Meta Dyrvig Kristensen , Manan Pareek , et al Added: 3 years ago
Hypertension is an important contributor to global morbidity and mortality and is a major burden on healthcare systems.1,2 More than 20% of the world’s population has high blood pressure when defined by conventional criteria: systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg.3,4 Even with therapeutic lifestyle and pharmacological measures, blood pressure remains poorly… View more

Heart Failure

Prevention & Chronic Conditions
ACS in the Elderly
Author(s): Mansi Oberoi , Nitesh Ainani , J Dawn Abbott , et al Added: 1 year ago

MI/ACS
Author(s): Judd E Hollander Added: 3 years ago
Ischemic heart disease is the leading cause of death among adults and one of the most common reasons for emergency department (ED) visits across the US. There are approximately five to seven million ED visits for acute chest pain syndromes annually; however, only 5% of these patients are ultimately diagnosed with acute myocardial infarction (AMI) and an additional 10% have non-AMI acute coronary… View more

MI/ACS
Author(s): Meshal Soni , Edo Y Birati Added: 3 years ago
The history of documented heart failure in medical literature dates back as early as the late 1700s, when William Withering recognized the therapeutic use of foxglove in patients with “dropsy”. The extract from the foxglove plant contained the cardiac glycoside digitalis, and edema – known as “dropsy” – was described in patients we now presume had the clinical syndrome of heart failure.1 Over the… View more

Heart Failure

Prevention & Chronic Conditions
Transcatheter Therapies for Tricuspid Valve Repair and Replacement
Author(s): Kusha Rahgozar , Sharon Bruoha , Edwin C Ho , et al Added: 2 years ago

Intervention